Clinical Trial Update: Growth and Development Study of Alglucosidase Alfa [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for alglucosidase alfa investigating growth and development in Pompe disease, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acid Maltase Deficiency Disease
• Glycogen Storage Disease Type Ii
• Pompe Disease

Drugs mentioned

• Alglucosidase alfa (alglucosidase alfa)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Pompe Disease, Glycogen Storage Disease Type II (GSD-II) | Phase 4 | Status: COMPLETED | Results posted: 2022-08-26